A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by XMLink in Annals of Dermatology
- Vol. 30 (6) , 688-693
Abstract
Park KY, et al. Ann Dermatol. 2018 Dec;30(6):688-693. https://doi.org/10.5021/ad.2018.30.6.688Keywords
Funding Information
- Meditox Inc
This publication has 25 references indexed in Scilit:
- Distribution and Expression of Non-Neuronal Transient Receptor Potential (TRPV) Ion Channels in RosaceaJournal of Investigative Dermatology, 2012
- Clinical, Cellular, and Molecular Aspects in the Pathophysiology of RosaceaJournal of Investigative Dermatology Symposium Proceedings, 2011
- Neurovascular and Neuroimmune Aspects in the Pathophysiology of RosaceaJournal of Investigative Dermatology Symposium Proceedings, 2011
- A split-face study using Botulinum Toxin type B to decrease facial Erythema indexJournal of Cosmetic and Laser Therapy, 2011
- Pituitary Adenylate Cyclase Activating PolypeptideThe American Journal of Pathology, 2010
- TRPV1 acts as a synaptic protein and regulates vesicle recyclingJournal of Cell Science, 2010
- Activation of TRPV1 Mediates Calcitonin Gene-Related Peptide Release, Which Excites Trigeminal Sensory Neurons and Is Attenuated by a Retargeted Botulinum Toxin with Anti-Nociceptive PotentialThe Journal of Neuroscience, 2009
- Botulinum Toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skinPain, 2007
- DECREASED SENSORY RECEPTORS P2X 3 AND TRPV1 IN SUBUROTHELIAL NERVE FIBERS FOLLOWING INTRADETRUSOR INJECTIONS OF BOTULINUM TOXIN FOR HUMAN DETRUSOR OVERACTIVITYJournal of Urology, 2005
- Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine TherapyHeadache: The Journal of Head and Face Pain, 2004